RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
RPTTX
Price
$45.87
Change
-$0.05 (-0.11%)
Updated
Sep 20 closing price
Ad is loading...

RPTIX vs RPTTX

Header iconRPTIX vs RPTTX Comparison
Open Charts RPTIX vs RPTTXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Diversified Mid Cap Gr I
Price$45.87
Change-$0.05 (-0.11%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPTIX vs RPTTX Comparison Chart
Loading...
VS
RPTIX vs. RPTTX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a StrongBuy and RPTTX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. RPTTX (2.46B). RPTIX pays higher dividends than RPTTX: RPTIX (0.18) vs RPTTX (0.04). RPTIX was incepted earlier than RPTTX: RPTIX (9 years) vs RPTTX (7 years). RPTTX is a more actively managed with annual turnover of: 49.70 vs. RPTIX (21.70). RPTIX (500000) and RPTTX (500000) have matching initial minimum investment requirements. RPTTX annual gain was more profitable for investors over the last year : 20.90 vs. RPTIX (14.81). RPTTX return over 5 years is better than : 31.70 vs. RPTIX (15.09).
RPTIXRPTTXRPTIX / RPTTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years7 years-
Gain YTD9.12714.56063%
Front LoadN/AN/A-
Min. Initial Investment500000500000100%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B2.46B1,274%
Annual Yield % from dividends0.180.04421%
Returns for 1 year14.8120.9071%
Returns for 3 years-13.57-11.64117%
Returns for 5 years15.0931.7048%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp